Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries.
Moses Badio;
Edouard Lhomme;
Mark Kieh;
Abdoul Habib Beavogui;
Stephen B Kennedy;
Seydou Doumbia;
Bailah Leigh;
Samba O Sow;
Alpha Diallo;
Daniela Fusco;
+16 more...
Matthew Kirchoff;
Monique Termote;
Renaud Vatrinet;
Deborah Wentworth;
Helène Esperou;
H Clifford Lane;
Jerome Pierson;
Deborah Watson-Jones ;
Céline Roy;
Eric D'Ortenzio;
Brian Greenwood ;
Genevieve Chêne;
Laura Richer;
James D Neaton;
Yazdan Yazdanpanah;
PREVAC study team;
PREVAC study team;
(2021)
Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries.
Trials, 22 (1).
583-.
ISSN 1745-6215
DOI: 10.1186/s13063-021-05572-3
Following the publication of the original article [1], we were notified of an error in the affiliation of 3 authors of the article: Celine Roy, Laura Richert and Genevieve Chene. Their affiliation was initially mentioned as: “Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia” However, their correct affiliation is: Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France.tp.
Item Type | Article |
---|---|
Elements ID | 165979 |
ORCID: https://orcid.org/0000-0001-6247-1746
ORCID: https://orcid.org/0000-0001-5725-9118